Viewing nowRosuvastatin Calcium Tablet 20 mg
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Keps Bio Pharma Co., Ltd.

MFDS item code 201403883 · Approved 2014.08.20 · Insurance code 693201020
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
This medication is used as an adjunctive therapy when dietary control and exercise alone are insufficient for patients with primary hypercholesterolemia and mixed dyslipidemia. It is also administered in conjunction with dietary modification or other therapies to help lower blood cholesterol levels in patients with homozygous familial hypercholesterolemia. It helps to regulate total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, slowing the progression of atherosclerosis. It is also used as an adjunct to diet in pediatric patients aged 10 to 17 years, particularly those with familial hypercholesterolemia. This medication is beneficial in patients with primary dysbetalipoproteinemia. It contributes to improving cardiovascular health by reducing the risks of stroke, myocardial infarction, and revascularization procedures in patients at high risk for cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and should continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily; the dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, based on LDL cholesterol levels, treatment goals, and patient response, and may be increased up to a maximum of 20 mg once daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 years to 17 years): The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) Children younger than 10 years: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, individuals allergic to any ingredient of this medication, patients with severe liver dysfunction, those with muscular disorders, and women who are pregnant or breastfeeding should not take this medication. Additionally, caution is required for patients with significantly impaired renal function or those taking certain medications concurrently. This medication can affect liver function, so individuals with a history of liver disease or excessive alcohol consumption should undergo liver function tests prior to use. If symptoms of muscle pain or weakness occur, the physician should be informed immediately, and in severe cases, discontinuation of the medication may be necessary. Periodic renal function tests are recommended, especially when taking high doses, as it may affect renal function. This medication may elevate blood sugar levels in some patients, so individuals at risk for diabetes should regularly monitor their blood sugar. Furthermore, this medication can interact with other drugs, so it is crucial to inform the physician or pharmacist of any other medications being taken. Women of childbearing potential should ensure appropriate contraception and should not use this medication if they are pregnant or planning to become pregnant. There is no specific antidote for overdose, so symptomatic treatment and tests for liver and muscle function may be necessary. Finally, dizziness may occur during treatment with this medication, so care should be taken when driving or operating machinery.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture and should be stored in a tightly closed container. It is recommended to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature to preserve the efficacy of the medication.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Keps Bio Pharma Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.